Global Orthobiologics Market is Estimated to Grow at a CAGR of 6.7%

“The global orthobiologics market is estimated to grow at a CAGR of 6.7% from 2014 to 2019. 
The end-user segment of this market is classified into hospitals, orthopedic clinics, and other end-users. Rise in cases of road accidents, as well as increasing awareness among patients with regards to the benefits associated with orthobiologics products are propelling the growth of orthobiologics market. The companies operating in this market have been stressing on new product developments, and mergers and acquisitions in order to establish their position in this highly competitive market. 
The report has profiled leading players of this market along with recent developments (new product launches and partnerships, mergers and acquisitions, and joint ventures) and growth strategies adopted by them to sustain their position in the global orthobiologics market. Major players of the global orthobiologics market are Biomet, Inc. (U.S.), Medtronic, Plc. (U.S.), Integra Life Sciences Corporation (U.S.)., Stryker Corporation (U.S.), Zimmer, Inc. (U.S.), DePuy Synthes (U.S.), Tornier, Inc. (Netherlands), Nuvasive, Inc. (U.S.), Exactech, Inc. (U.S.), Globus Medical, Inc. (U.S.), and Wright Medical Technology, Inc. (U.S.).